{
    "clinical_study": {
        "@rank": "40193", 
        "arm_group": [
            {
                "arm_group_label": "Dymista", 
                "arm_group_type": "Active Comparator", 
                "description": "(azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137mcg/50mcg: Mode of Administration:  Topical/intranasal spray\nDose:  548 mcg azelastine hydrochloride / 200 mcg fluticasone propionate, total daily dose Regimen: 1 spray per nostril twice daily"
            }, 
            {
                "arm_group_label": "Dymista vehicle", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Dose: vehicle only Regimen: 1 spray per nostril twice daily"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine if Dymista nasal spray is better and safer than\n      placebo in treating children ages 4 to <12 years old who have seasonal allergic rhinitis."
        }, 
        "brief_title": "Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)", 
        "condition": "Seasonal Allergic Rhinitis", 
        "condition_browse": {
            "mesh_term": [
                "Rhinitis, Allergic, Seasonal", 
                "Rhinitis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male and female subjects ages >4 years to <12 years of age, inclusive at the\n             screening visit\n\n          -  The parent/caregiver must provide written informed consent and the child must provide\n             pediatric assent, if possible\n\n          -  Willing and able to comply with the study requirements\n\n          -  Have a history of seasonal allergic rhinitis (SAR) to pollen in the prevailing\n             allergy season.\n\n          -  The presence of immunoglobulin E (IgE)-mediated hypersensitivity to prevailing\n             pollen, confirmed by a positive response to skin prick test.  A histamine skin test\n             must also be positive. A positive response for both the pollen skin test and the\n             histamine skin test is defined as a wheal diameter of at least 4 mm larger than the\n             negative saline control\n\n          -  General good health and free of any disease or concomitant treatment that could\n             interfere with the interpretation of the study results as determined by the\n             investigator or the sponsor's medical officer\n\n          -  On the first day of the placebo lead-in period (Visit 1) subjects must have a 12-hour\n             reflective total nasal symptoms score (rTNSS )of \u22656 and a reflective congestion score\n             of \u22652 to qualify for entry.\n\n        At Visit 2:\n\n          -  Have taken at least 6 doses of the placebo lead-in medication during the placebo\n             lead-in period\n\n          -  At Visit 2, to be eligible for entry into the double-blind treatment period, subjects\n             must have the total of the seven lead-in symptom assessments  during the past 3 days\n             of the lead-in period including the Day of Randomization (Visit 2, Day 1):\n\n               -  a 12-hour reflective TNSS \u2265 42\n\n               -  a 12-hour reflective congestion score of \u226514\n\n        Exclusion Criteria:\n\n          -  On nasal examination, the presence of any superficial or moderate nasal mucosal\n             erosion, nasal mucosal ulceration, or nasal septum perforation (Grade 1B - 4) at\n             either the screening visit or randomization visit\n\n          -  Nasal disease(s) likely to affect deposition of intranasal medication, such as acute\n             or chronic sinusitis, rhinitis medicamentosa, clinically significant polyposis, or\n             clinically significant nasal structural abnormalities.\n\n          -  Nasal surgery or sinus surgery within the previous year.\n\n          -  The use of any investigational drug within 30 days prior to signing the informed\n             consent/pediatric assent at Visit 1.  No investigational products are permitted for\n             use during the conduct of this study\n\n          -  Presence of any hypersensitivity to azelastine hydrochloride and/or fluticasone\n             propionate or drugs similar to azelastine hydrochloride and/or fluticasone propionate\n\n          -  Respiratory tract infections within 14 days prior to Visit1\n\n          -  Significant pulmonary disease including asthma. Subjects with intermittent asthma who\n             only require short-acting inhaled bronchodilators (not more often than twice per\n             week) and who do not have nocturnal awakening as a result of asthma are eligible for\n             enrollment\n\n          -  Chronic obstructive sleep apnea syndrome (clinical diagnosis)\n\n          -  Existence of any surgical or medical condition, which in the opinion of the\n             investigator or sponsor's medical monitor, might significantly alter the absorption,\n             distribution, metabolism, or excretion of study drug that might significantly affect\n             the subject's ability to complete this trial\n\n          -  Clinically relevant abnormal physical findings which, in the opinion of the\n             investigator or sponsor's medical monitor, would interfere with the objectives of the\n             study or that may preclude compliance with the study procedures\n\n          -  Family members of the research center or private practice personnel who are directly\n             involved in this study are excluded\n\n          -  Members of the same household cannot be enrolled at the same time\n\n          -  Subjects who have used medications or therapies that could interfere with safety and\n             efficacy evaluations and have not had the proper washouts from these medications or\n             therapies\n\n          -  Any behavioral condition which could affect subject's ability to accurately report\n             symptoms to the caregiver such as developmental delay, attention deficit disorder,\n             and autism\n\n          -  Positive pregnancy test in female subjects \u2265 9 years of age\n\n          -  Females who are pregnant or nursing\n\n          -  Females of childbearing potential who are not abstinent and not practicing a\n             medically acceptable method of contraception\n\n          -  Subjects who fail to complete the symptom diary during the lead-in period, defined as\n             missing data for >50% of entries\n\n          -  Subjects receiving immunotherapy injections (antigen desensitization) must be on a\n             stable maintenance regimen for at least 30 days before the first study visit\n             (adjustments to regimens following a brief period of missed injections do not\n             preclude participation). Dose reduction when a new bottle is used does not preclude\n             participation.\n\n          -  Planned travel outside of the pollen area during the study period"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "11 Years", 
            "minimum_age": "4 Years"
        }, 
        "enrollment": {
            "#text": "348", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01915823", 
            "org_study_id": "MP 4008"
        }, 
        "intervention": [
            {
                "arm_group_label": "Dymista", 
                "intervention_name": "azelastine hydrochloride and fluticasone propionate", 
                "intervention_type": "Drug", 
                "other_name": "Dymista"
            }, 
            {
                "arm_group_label": "Dymista vehicle", 
                "intervention_name": "Dymista vehicle", 
                "intervention_type": "Drug", 
                "other_name": "placebo"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Azelastine", 
                "Fluticasone"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "March 24, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35209"
                    }, 
                    "name": "Clinical Research Center of Alabama,LLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Little Rock", 
                        "country": "United States", 
                        "state": "Alaska", 
                        "zip": "72205"
                    }, 
                    "name": "Little Rock Allergy and Asthma Clinical research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30342"
                    }, 
                    "name": "Clinical Research Atlanta"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Savannah", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "31406"
                    }, 
                    "name": "Aeroallergy Research Laboratories of Savannah"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stockbridge", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30281"
                    }, 
                    "name": "Atlanta Allergy and Asthma Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Normal", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "61761"
                    }, 
                    "name": "Sneeze, Wheeze and Itch Associates"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46208"
                    }, 
                    "name": "Clinical Research Institute of Indiana"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Louisville", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40215"
                    }, 
                    "name": "Family Allergy and Asthma Reserach"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wheaton", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "20902"
                    }, 
                    "name": "Institute for Asthma and Allergy PC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ypsilanti", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48197"
                    }, 
                    "name": "Respiratory Medicine Research Institute of Michigan"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Plymouth", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55402"
                    }, 
                    "name": "Clinical Research Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63141"
                    }, 
                    "name": "The Clinical Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Warrensburg", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "64093"
                    }, 
                    "name": "Clinical Research of the Ozarks,Inc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mount Laurel", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "08054"
                    }, 
                    "name": "Allergy and Asthma Research NJ inc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ocean", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07712"
                    }, 
                    "name": "Atlantic Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Skillman", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "08558"
                    }, 
                    "name": "Princeton Center for Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Raleigh", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27607"
                    }, 
                    "name": "North Carolina Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45231"
                    }, 
                    "name": "Bernstein Clinical Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oklahoma City", 
                        "country": "United States", 
                        "state": "Oklahoma", 
                        "zip": "73120"
                    }, 
                    "name": "Allergy, Asthma & Clinical Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oklahoma City", 
                        "country": "United States", 
                        "state": "Oklahoma", 
                        "zip": "73131"
                    }, 
                    "name": "Oklahoma Institute of Allergy and Asthma"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Blue Bell", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19422"
                    }, 
                    "name": "Allergy and Asthma Specialist PC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Upland", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19013"
                    }, 
                    "name": "Asthma and Allergy Research Associate"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charleston", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29414"
                    }, 
                    "name": "Allergy and Asthma Consultants, LLP"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charleston", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29407"
                    }, 
                    "name": "National Allergy, Asthma and Urticaria of Charleston"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ausitn", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78731"
                    }, 
                    "name": "Isis Clinical Research, LLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Austin", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78759"
                    }, 
                    "name": "Sirius Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Braunfels", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78130"
                    }, 
                    "name": "Central Texas Health Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78233"
                    }, 
                    "name": "Live Oak Allergy and Asthma Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78229"
                    }, 
                    "name": "Sylvana Research Associates"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Waco", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "76712"
                    }, 
                    "name": "Allergy Asthma Research Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Waco", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "76712"
                    }, 
                    "name": "Immunology/allergy and asthma Care of Waco"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized, Double-Blind Trial of the Safety and Efficacy of Dymista Nasal Spray Compared to Placebo Nasal Spray in the Treatment of Children Ages >4 Years to <12 Years With Seasonal Allergic Rhinitis", 
        "other_outcome": {
            "description": "Change from baseline to Visits 3 and 4 in the Pediatric Rhinoconjunctivitis Quality of Life Questionnaire (PRQLQ) in subjects \u22656 years of age", 
            "measure": "Pediatric Rhinoconjunctivitis Quality of Life Questionnaire (PRQLQ)", 
            "safety_issue": "No", 
            "time_frame": "day 1 to day 15 of treatment"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "primary efficacy", 
            "safety_issue": "No", 
            "time_frame": "15 days of treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01915823"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Subject-reported adverse experiences (incidence, type, and severity of adverse events)\nNasal Examinations\nVital signs assessments", 
            "measure": "Safety", 
            "safety_issue": "Yes", 
            "time_frame": "entire length of study (day 1 to day 22)"
        }, 
        "source": "Meda Pharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Meda Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}